1.Magnetic resonance spectroscopy in observing thalamus metabolism of patients with multiple sclerosis or neuromyelitis optica
Xuan CHEN ; Yongmei LI ; Tianyou LUO ; Yu OUYANG ; Fajin LV ; Chun ZENG ; Zhongping WANG
Chinese Journal of Interventional Imaging and Therapy 2011;08(5):380-383
ObjectiveTo investigate the variation of thalamus metabolism in patients with multiple sclerosis (MS) or neuronmyelitis optica (NMO) using 1H-MRS.Methods1H-MRS was performed to 32 MS patients (MS group),28 NMO patients (NMO group) and 35 healthy volunteers (normal control group).The ratios of metabolism in thalamus,including N-acetylaspartic acid/creatine (NAA/Cr),choline/creatine (Cho/Cr) and myo-inositol/creatine (mI/Cr) were calculated and compared.ResultsThere was statistical difference of NAA/Cr in thalamus among the three groups (P<0.05).NAA/Cr in thalamus of MS group was significantly lower than that of normal control group (t= -3.45,P<0.05),while no statistical difference of Cho/Cr and mI/Cr was found (t=0.086,0.661,all P>0.05).No statistical difference of NAA/Cr,Cho/Cr or ml/Cr was found between NMO group and normal control group (t=-0.792,1.408,1.735,all P>0.05).Conclusion1H-MRS shows the decrease of thalamus NAA/Cr that suggesting axon damage in MS patients,but in NMO patients no same result is found.1 H-MRS can reflect the pathological changes of MS and NMO,and improve the differential diagnosis of the two diseases.
2.Determination of plasma homocysteine in oligospermia and/or asthenospermia patients.
Yi-Feng GE ; Chun-Hui WANG ; Luo-Xuan OUYANG ; Yong SHAO ; Bing YAO ; Xin-Yi XIA ; Xue-Jun SHANG ; Yu-Feng HUANG
National Journal of Andrology 2008;14(12):1112-1114
OBJECTIVETo detect the level of fasting plasma homocysteine (Hcy) in patients with oligospermia and/or asthenospermia and to investigate its clinical significance.
METHODSSemen quality analyses and fasting plasma Hcy determination were performed for 86 infertility patients (21 with oligospermia, 32 with asthenospermia and 33 with oligo-asthenospermia) and 19 normal fertile volunteers. The results were compared.
RESULTSThe level of plasma Hcy was significantly higher in the infertility patients than in the normal controls (P < 0.05) and negatively correlated with sperm concentration (r = -0.433, P < 0.01), the percentage of grade a sperm (r = -0.303, P < 0.05) and the percentage of grade a+b sperm (r = -0.339, P < 0.01).
CONCLUSIONThe increased level of human plasma Hcy directly or indirectly affects spermatogenesis and correlates negatively with oligospermia and/or asthenospermia.
Adult ; Asthenozoospermia ; blood ; Case-Control Studies ; Homocysteine ; blood ; Humans ; Male ; Oligospermia ; blood ; Sperm Count ; Sperm Motility
3.Biological assay in quality control of animal medicines.
Xuan WANG ; Luo-Dan OUYANG ; Chun-Mei DAI ; Li MA ; Xiao-He XIAO
China Journal of Chinese Materia Medica 2017;42(12):2228-2235
Animal medicine is a unique part of traditional Chinese medicine. They have strong effects, but their effective compounds are not entirely known. The efficiency and safety of animal medicines can't be effectively controlled by current quality assurance system and evaluation method, which has deeply influenced the development of animal medicines. Biological assay does not focus on efficacy of single component, but directly reflects the pharmacodynamics and safety of animal medicines by biological effect. With the development of biotechnology, many new technologies have emerged, such as biochip and high content analysis. Based on the related targets, pathways and key biochemical factors, the field of biological assay has been expanded. With advantages of pharmacology andoverall controllability, as well as the characteristics of in line with the quality control of Chinese Medicine, biological assay will become one of the important development directionsfor quality standardization of animal medicines.
4.Ultrasonographic Characteristics of Cortical Sulcus Development in the Human Fetus between 18 and 41 Weeks of Gestation.
Xi CHEN ; Sheng-Li LI ; Guo-Yang LUO ; Errol R NORWITZ ; Shu-Yuan OUYANG ; Hua-Xuan WEN ; Ying YUAN ; Xiao-Xian TIAN ; Jia-Min HE
Chinese Medical Journal 2017;130(8):920-928
BACKGROUNDFetal brain development is a complicated process that continues throughout pregnancy. Fetal sulcus development has typical morphological features. Assessment of fetal sulcus development to understand the cortical maturation and development by prenatal ultrasound has become widespread. This study aimed to explore a reliable method to assess cortical sulcus and to describe the normal sonographic features of cortical sulcus development in the human fetus between 18 and 41 weeks of gestation.
METHODSA cross-sectional study was designed to examine the fetal cortical sulcus development at 18-41 weeks of gestation. Ultrasound was used to examine the insula, sylvian fissure (SF), parieto-occipital fissure (POF), and calcarine fissure (CF). Bland-Altman plots were used for assessing the concordance, and the intraclass correlation coefficient was used for assessing the reliability.
RESULTSSF images were successfully obtained in 100% of participants at 22 weeks of gestation, while the POF images and CF images could be obtained in 100% at 23 weeks of gestation and 24 weeks of gestation, respectively. The SF width, temporal lobe depth, POF depth, and the CF depth increased with the developed gestation. The width of uncovered insula and the POF angle decreased with the developed gestation. By 23 weeks of gestation, the insula was beginning to be covered. Moreover, it completed at 35 weeks of gestation. The intra- and inter-observer agreements showed consistent reproducibility.
CONCLUSIONSThis study defined standard views of the fetal sulcus as well as the normal reference ranges of these sulcus measurements between 18 and 41 weeks of gestation. Such ultrasonographic measurements could be used to identify fetuses at risk of fetal neurological structural disorders.
Adult ; Brain ; embryology ; Cross-Sectional Studies ; Female ; Fetal Development ; physiology ; Fetus ; embryology ; Gestational Age ; Humans ; Pregnancy ; Ultrasonography, Prenatal ; methods
5.Lipid-lowering effects of oleanolic acid in hyperlipidemic patients.
Han-Qiong LUO ; Jie SHEN ; Cai-Ping CHEN ; Xiao MA ; Chao LIN ; Qiong OUYANG ; Chun-Xiao XUAN ; Jine LIU ; Hong-Bin SUN ; Jun LIU
Chinese Journal of Natural Medicines (English Ed.) 2018;16(5):339-346
Oleanolic acid (OA) is a pentacyclic triterpenoid compound extracted from olea europaeal, a traditional Chinese medicine herb. OA has been used in the clinic as a hepatoprotective medicine in China since 1970s. In our previous study, we observed that OA could ameliorate hyperlipidemia in animal models. In the present study, we conducted a small-scale clinical trial to evaluate the hypolipidemia effect of OA in hyperlipidemic patients. Hyperlipidemic patients were administrated with OA for four weeks (4 tablets once, three times a day). The blood samples of the patients were collected before and after OA treatment. The biological parameters were measured. Furthermore, three patients' blood samples were studied with DNA microarray. After OA administration, the TC, TG, and HDLC levels in serum decreased significantly. DNA microarray analysis results showed that the expressions of 21 mRNAs were significantly changed after OA treatment. Bioinformatics analysis showed 17 mRNAs were up-regulated and 4 mRNAs were down-regulated significantly after OA treatment. Five mRNAs (CACNA1B, FCN, STEAP3, AMPH, and NR6A1) were selected to validate the expression levels by qRT-PCR. Therefore, OA administration differentially regulated the expression of genes involved in lipid metabolism. The data showed a clinical evidence that OA could improve hyperlipidemia and also unveiled a new insight into the molecular mechanisms underlying the pharmacological effect of OA on hyperlipidemia.
China
;
Computational Biology
;
Drugs, Chinese Herbal
;
pharmacology
;
therapeutic use
;
Female
;
Gene Expression Profiling
;
Gene Expression Regulation
;
drug effects
;
Humans
;
Hyperlipidemias
;
blood
;
drug therapy
;
genetics
;
metabolism
;
Lipid Metabolism
;
drug effects
;
Male
;
Middle Aged
;
Oleanolic Acid
;
pharmacology
;
therapeutic use
;
RNA, Messenger
;
genetics
;
Treatment Outcome